Antithrombin III Tours gene: Identification of a point mutation leading to an arginine—cysteine replacement in a silent deficiency
Open Access
- 11 March 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 14 (5) , 2408
- https://doi.org/10.1093/nar/14.5.2408
Abstract
Nathalie Duchange, Jean-François Chassé, Georges N. Cohen, Mario M. Zakin; Antithrombin III Tours gene: Identification of a point mutation leading to an argininKeywords
This publication has 5 references indexed in Scilit:
- Modified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries.Proceedings of the National Academy of Sciences, 1985
- An abnormal plasma antithrombin with no apparent affinity for heparinThrombosis Research, 1984
- Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.Proceedings of the National Academy of Sciences, 1984
- Isolation of a cDNA clone for human antithrombin III.Journal of Biological Chemistry, 1983
- Antithrombin III toyama: A hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitisThrombosis Research, 1983